Skip to content

Investigation of the Effects of Sedentary Behaviour and Moderate Exercise on Glucose Tolerance and Insulin Sensitivity

Investigation of the Effects of Sedentary Behaviour and Moderate Exercise on Glucose Tolerance and Insulin Sensitivity

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03827239
Enrollment
6
Registered
2019-02-01
Start date
2019-01-17
Completion date
2019-12-31
Last updated
2021-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Metabolism, Insulin Sensitivity, Sedentary Lifestyle

Brief summary

Individuals with pre-diabetes or diabetes would benefit from low impact methods that would improve their insulin sensitivity and aid in maintaining glucose homeostasis. Physical activity helps the body decrease its insulin resistance and burn excess sugar. Many diabetics also suffer from obesity and specific forms or durations of physical exercise may not be viable options for these individuals. Determining whether short bursts of moderate exercise improve blood glucose levels in healthy humans may identify a further method for diabetics to improve their glucose homeostasis. The aim of this study is to determine the most effective moderate exercise that can be completed in 3 minutes and its effectiveness on improving glucose handling, in response to a single day of standardized high-fat and high-carbohydrate feeding in comparison to periods of prolonged sitting.

Interventions

OTHERActivity/Moderate Exercise

3-hour sedentary period with 3 minute activity breaks of moderate exercise every 30 minutes

Sponsors

University of Prince Edward Island
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy * BMI between 18-30 kg/m² * non-smoker

Exclusion criteria

* pregnant * diabetes * kidney disease * liver disease * cardiovascular disease * cancer

Design outcomes

Primary

MeasureTime frameDescription
Change in Insulin levelsPre-prandial baseline (12 hours fasted) and 3 hours post-prandial on each of two testing daysThe change in blood insulin levels from baseline (12 hours fasted) to 3-hours post-prandial will be determined from blood serum using a human metabolic hormone multiplex panel (Luminex xMAP technology).
Change in concentration of C-peptidePre-prandial baseline (12 hours fasted) and 3 hours post-prandial on each of two testing daysThe change in blood C-peptide levels from baseline (12 hours fasted) to 3-hours post-prandial will be determined from blood serum using a human metabolic hormone multiplex panel (Luminex xMAP technology).
Changes in blood glucose levelsBaseline and every 30-60 minutes over 3 hours (6 timepoints per test day)Blood glucose levels will be determined at pre-prandial baseline and over the following 3-hour testing period using hand-held blood glucose meters.
Change in metabolomic response to a test mealPre-prandial and 3-hours post test meal through study completionTargeted metabolomics analysis of approximately 139 metabolites in blood serum by LC-MS/MS to generate a metabolomic profile in response to a high-fat and high-carbohydrate test meal. Metabolites to be determined are categorized as biogenic amines, amino acids, histidines, carboxylic acids, acylcarnitines, glycerophospholipids and organic acids.

Secondary

MeasureTime frameDescription
Immediate effects of short-term sedentary behaviour on cognitive function3 hours post-activity (sedentary behaviour or exercise) on test days through study completionAssessing cognitive abilities using the Stroop Test.
Gene expression levels in isolated PBMC populationsPre-prandial and 3 hours post-prandial on on test days through study completionDetermining changes in gene expression in pathways associated with RAGE signalling.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026